Norges Bank reports 7.73% stake in Upstream Bio
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Norges Bank, the central bank of Norway and an investment adviser, reports its beneficial ownership of common stock of Upstream Bio, Inc. on an amended Schedule 13G. Norges Bank reports beneficial ownership of 4,206,586 shares of common stock, representing 7.7299% of the class.
Of this position, Norges Bank has 3,768,619 shares with sole power to vote and 3,768,619 shares with sole power to dispose. It reports 437,967 shares with shared power to dispose and no shared voting power. Certain shares are reported as invested on behalf of the Government of Norway, and Norges Bank certifies that its foreign regulatory scheme is substantially comparable to that of functionally equivalent U.S. institutions.
Key Figures
Key Terms
beneficially owned financial
Sole Voting Power financial
Sole Dispositive Power financial
Schedule 13D regulatory
Investment Adviser financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What percentage of Upstream Bio (UPB) does Norges Bank hold according to this filing?
How much voting power does Norges Bank have in Upstream Bio (UPB)?
Who is the filing person and what is their role regarding Upstream Bio (UPB)?
When was this Upstream Bio (UPB) Schedule 13G/A certification signed and by whom?
AI-generated analysis. How Rhea-AI works. Not financial advice.